Core--DNA sequencing

$0P30FY2002CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications & trials

Paper 39764096 Paper 39713458 Paper 39711546 Paper 39684829 Paper 39682260 Paper 39673545 Paper 39574628 Paper 39554078 Paper 39553975 Paper 39483879 Paper 39478207 Paper 39478033 Paper 39427081 Paper 39423129 Paper 39401530 Paper 39386686 Paper 39386654 Paper 39361429 Paper 39352498 Paper 39345818 Paper 39334471 Paper 39333091 Paper 39325576 Paper 39303018 Paper 39298488 Paper 39292922 Paper 39264172 Paper 39259768 Paper 39259676 Paper 39231036 Paper 39229013 Paper 39226717 Paper 39189477 Paper 39169060 Paper 39167600 Paper 39151020 Paper 39149405 Paper 39145457 Paper 39136986 Paper 39133759 Paper 39132840 Paper 39114287 Paper 39112491 Paper 39105738 Paper 39090647 Paper 39058602 Paper 39048708 Paper 39030444 Paper 39026866 Paper 39018351 Paper 38978579 Paper 38950084 Paper 38947092 Paper 38935887 Paper 38935155 Paper 38922866 Paper 38921453 Paper 38915549 Paper 38909741 Paper 38895370 Paper 38886716 Paper 38886379 Paper 38867043 Paper 38855542 Paper 38846687 Paper 38836758 Paper 38826485 Paper 38823390 Paper 38816749 Paper 38815928 Paper 38806891 Paper 38795603 Paper 38780906 Paper 38775890 Paper 38766114 Paper 38746351 Paper 38744613 Paper 38741014 Paper 38731867 Paper 38729350 Paper 38720808 Paper 38712281 Paper 38700926 Paper 38699373 Paper 38697998 Paper 38687247 Paper 38682900 Paper 38652829 Paper 38645082 Paper 38631913 Paper 38617241 Paper 38604528 Paper 38604128 Paper 38602070 Paper 38600351 Paper 38591270 Paper 38585888 Paper 38553325 Paper 38551504 Paper 38548990

Abstract

The DNA Sequencing Shared Resource provides low cost, and high quality DNA Sequencing and fluorescent DNA fragment analysis (GeneScan) services to Cancer Center investigators. During the past 4 years, this resource has served nearly 100 investigators from various Cancer Center programs. This resource has been successful in meeting the requests for its service with a short turnaround time of three days. The facility will continue to provide both existing and new services to the Cancer Center investigators.

View original record on NIH RePORTER →